nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Progesterone—uterine cancer	0.157	0.388	CbGbCtD
Esomeprazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.114	0.283	CbGbCtD
Esomeprazole—CYP3A4—Progesterone—uterine cancer	0.0758	0.188	CbGbCtD
Esomeprazole—CYP3A4—Etoposide—uterine cancer	0.0339	0.0839	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—uterine cancer	0.0231	0.0573	CbGbCtD
Esomeprazole—Omeprazole—CYP11A1—uterine cancer	0.00812	1	CrCbGaD
Esomeprazole—Dysphagia—Epirubicin—uterine cancer	0.000348	0.000592	CcSEcCtD
Esomeprazole—Thrombocytopenia—Etoposide—uterine cancer	0.000346	0.000588	CcSEcCtD
Esomeprazole—Tachycardia—Etoposide—uterine cancer	0.000345	0.000587	CcSEcCtD
Esomeprazole—Skin disorder—Etoposide—uterine cancer	0.000343	0.000584	CcSEcCtD
Esomeprazole—Dry skin—Doxorubicin—uterine cancer	0.000342	0.000581	CcSEcCtD
Esomeprazole—Hyperhidrosis—Etoposide—uterine cancer	0.000342	0.000581	CcSEcCtD
Esomeprazole—Pancreatitis—Epirubicin—uterine cancer	0.000341	0.000581	CcSEcCtD
Esomeprazole—Abdominal pain upper—Doxorubicin—uterine cancer	0.000341	0.000579	CcSEcCtD
Esomeprazole—Hypokalaemia—Doxorubicin—uterine cancer	0.000339	0.000577	CcSEcCtD
Esomeprazole—Angina pectoris—Epirubicin—uterine cancer	0.000339	0.000577	CcSEcCtD
Esomeprazole—Breast disorder—Doxorubicin—uterine cancer	0.000337	0.000573	CcSEcCtD
Esomeprazole—Anorexia—Etoposide—uterine cancer	0.000337	0.000573	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000336	0.000571	CcSEcCtD
Esomeprazole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000336	0.000571	CcSEcCtD
Esomeprazole—Diarrhoea—Dactinomycin—uterine cancer	0.000334	0.000568	CcSEcCtD
Esomeprazole—Pancytopenia—Epirubicin—uterine cancer	0.000331	0.000563	CcSEcCtD
Esomeprazole—Gastritis—Doxorubicin—uterine cancer	0.00033	0.000561	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000329	0.000559	CcSEcCtD
Esomeprazole—Muscular weakness—Doxorubicin—uterine cancer	0.000329	0.000559	CcSEcCtD
Esomeprazole—Dysuria—Epirubicin—uterine cancer	0.000326	0.000554	CcSEcCtD
Esomeprazole—Neutropenia—Epirubicin—uterine cancer	0.000326	0.000554	CcSEcCtD
Esomeprazole—Abdominal distension—Doxorubicin—uterine cancer	0.000324	0.000552	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000324	0.000551	CcSEcCtD
Esomeprazole—Influenza—Doxorubicin—uterine cancer	0.000322	0.000548	CcSEcCtD
Esomeprazole—Asthma—Doxorubicin—uterine cancer	0.000322	0.000548	CcSEcCtD
Esomeprazole—Dysphagia—Doxorubicin—uterine cancer	0.000322	0.000548	CcSEcCtD
Esomeprazole—Pollakiuria—Epirubicin—uterine cancer	0.000322	0.000547	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.000318	0.000541	CcSEcCtD
Esomeprazole—Paraesthesia—Etoposide—uterine cancer	0.000317	0.00054	CcSEcCtD
Esomeprazole—Weight increased—Epirubicin—uterine cancer	0.000317	0.000539	CcSEcCtD
Esomeprazole—Pancreatitis—Doxorubicin—uterine cancer	0.000316	0.000537	CcSEcCtD
Esomeprazole—Weight decreased—Epirubicin—uterine cancer	0.000315	0.000536	CcSEcCtD
Esomeprazole—Dyspnoea—Etoposide—uterine cancer	0.000315	0.000536	CcSEcCtD
Esomeprazole—Somnolence—Etoposide—uterine cancer	0.000314	0.000534	CcSEcCtD
Esomeprazole—Angina pectoris—Doxorubicin—uterine cancer	0.000314	0.000534	CcSEcCtD
Esomeprazole—Infestation NOS—Epirubicin—uterine cancer	0.000311	0.000528	CcSEcCtD
Esomeprazole—Infestation—Epirubicin—uterine cancer	0.000311	0.000528	CcSEcCtD
Esomeprazole—Vomiting—Dactinomycin—uterine cancer	0.00031	0.000528	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000308	0.000524	CcSEcCtD
Esomeprazole—Rash—Dactinomycin—uterine cancer	0.000308	0.000524	CcSEcCtD
Esomeprazole—Decreased appetite—Etoposide—uterine cancer	0.000307	0.000522	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—uterine cancer	0.000306	0.000521	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—uterine cancer	0.000305	0.000519	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000305	0.000519	CcSEcCtD
Esomeprazole—Fatigue—Etoposide—uterine cancer	0.000305	0.000518	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—uterine cancer	0.000303	0.000515	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—uterine cancer	0.000303	0.000515	CcSEcCtD
Esomeprazole—Pain—Etoposide—uterine cancer	0.000302	0.000514	CcSEcCtD
Esomeprazole—Constipation—Etoposide—uterine cancer	0.000302	0.000514	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—uterine cancer	0.000302	0.000513	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—uterine cancer	0.000302	0.000513	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—uterine cancer	0.000301	0.000513	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—uterine cancer	0.000301	0.000513	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000299	0.000509	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—uterine cancer	0.000298	0.000506	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—uterine cancer	0.000296	0.000504	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000294	0.0005	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000294	0.0005	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—uterine cancer	0.000293	0.000499	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—uterine cancer	0.000293	0.000498	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—uterine cancer	0.000292	0.000496	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—uterine cancer	0.000291	0.000496	CcSEcCtD
Esomeprazole—Feeling abnormal—Etoposide—uterine cancer	0.000291	0.000495	CcSEcCtD
Esomeprazole—Nausea—Dactinomycin—uterine cancer	0.00029	0.000493	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—uterine cancer	0.00029	0.000493	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000289	0.000491	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—uterine cancer	0.000287	0.000489	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—uterine cancer	0.000287	0.000489	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000285	0.000485	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—uterine cancer	0.000284	0.000483	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—uterine cancer	0.000282	0.00048	CcSEcCtD
Esomeprazole—Urticaria—Etoposide—uterine cancer	0.000281	0.000477	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—uterine cancer	0.00028	0.000476	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—uterine cancer	0.00028	0.000476	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—uterine cancer	0.000279	0.000475	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—uterine cancer	0.000279	0.000475	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—uterine cancer	0.000279	0.000475	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—uterine cancer	0.000279	0.000475	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—uterine cancer	0.000279	0.000475	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—uterine cancer	0.000279	0.000474	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—uterine cancer	0.000277	0.000472	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—uterine cancer	0.000277	0.000471	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—uterine cancer	0.000275	0.000468	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—uterine cancer	0.000275	0.000467	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—uterine cancer	0.000274	0.000466	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000274	0.000466	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—uterine cancer	0.000273	0.000465	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000272	0.000462	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—uterine cancer	0.000271	0.000461	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—uterine cancer	0.00027	0.000459	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—uterine cancer	0.000269	0.000457	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000268	0.000456	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—uterine cancer	0.000264	0.000448	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—uterine cancer	0.000263	0.000447	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—uterine cancer	0.000261	0.000443	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—uterine cancer	0.00026	0.000443	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—uterine cancer	0.00026	0.000442	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—uterine cancer	0.000259	0.00044	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—uterine cancer	0.000259	0.00044	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—uterine cancer	0.000258	0.000439	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—uterine cancer	0.000257	0.000437	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—uterine cancer	0.000256	0.000435	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000255	0.000433	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—uterine cancer	0.000254	0.000432	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—uterine cancer	0.000253	0.000431	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—uterine cancer	0.000253	0.000431	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—uterine cancer	0.000253	0.00043	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—uterine cancer	0.000252	0.000428	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—uterine cancer	0.000251	0.000427	CcSEcCtD
Esomeprazole—Chills—Epirubicin—uterine cancer	0.00025	0.000425	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—uterine cancer	0.00025	0.000425	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—uterine cancer	0.000249	0.000423	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—uterine cancer	0.000246	0.000419	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—uterine cancer	0.000244	0.000415	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000244	0.000415	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—uterine cancer	0.000243	0.000413	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—uterine cancer	0.000242	0.000411	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—uterine cancer	0.000241	0.00041	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—uterine cancer	0.00024	0.000409	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—uterine cancer	0.000239	0.000407	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—uterine cancer	0.000239	0.000407	CcSEcCtD
Esomeprazole—Tension—Epirubicin—uterine cancer	0.000238	0.000405	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—uterine cancer	0.000238	0.000404	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—uterine cancer	0.000236	0.000401	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—uterine cancer	0.000235	0.000399	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—uterine cancer	0.000234	0.000397	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—uterine cancer	0.000233	0.000397	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—uterine cancer	0.000233	0.000396	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—uterine cancer	0.000232	0.000395	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—uterine cancer	0.000231	0.000394	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—uterine cancer	0.000229	0.000389	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—uterine cancer	0.000228	0.000388	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—uterine cancer	0.000226	0.000384	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—uterine cancer	0.000225	0.000383	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—uterine cancer	0.000225	0.000382	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—uterine cancer	0.000225	0.000382	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—uterine cancer	0.000224	0.000382	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—uterine cancer	0.000223	0.000379	CcSEcCtD
Esomeprazole—Rash—Etoposide—uterine cancer	0.000223	0.000379	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—uterine cancer	0.000223	0.000379	CcSEcCtD
Esomeprazole—Headache—Etoposide—uterine cancer	0.000221	0.000377	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—uterine cancer	0.000221	0.000376	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—uterine cancer	0.00022	0.000375	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—uterine cancer	0.00022	0.000374	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—uterine cancer	0.000219	0.000372	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—uterine cancer	0.000218	0.000371	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—uterine cancer	0.000218	0.000371	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—uterine cancer	0.000217	0.00037	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—uterine cancer	0.000217	0.000369	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—uterine cancer	0.000216	0.000367	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—uterine cancer	0.000214	0.000365	CcSEcCtD
Esomeprazole—Cough—Epirubicin—uterine cancer	0.000212	0.00036	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—uterine cancer	0.000212	0.00036	CcSEcCtD
Esomeprazole—Nausea—Etoposide—uterine cancer	0.00021	0.000357	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—uterine cancer	0.00021	0.000356	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—uterine cancer	0.000208	0.000354	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—uterine cancer	0.000208	0.000353	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—uterine cancer	0.000207	0.000351	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—uterine cancer	0.000207	0.000351	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—uterine cancer	0.000207	0.000351	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—uterine cancer	0.000206	0.000351	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—uterine cancer	0.000206	0.00035	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000205	0.000349	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—uterine cancer	0.000204	0.000347	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—uterine cancer	0.000202	0.000344	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—uterine cancer	0.000202	0.000344	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—uterine cancer	0.000202	0.000343	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—uterine cancer	0.000201	0.000342	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—uterine cancer	0.0002	0.00034	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—uterine cancer	0.000198	0.000338	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—uterine cancer	0.000198	0.000337	CcSEcCtD
Esomeprazole—Infection—Epirubicin—uterine cancer	0.000197	0.000335	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—uterine cancer	0.000196	0.000333	CcSEcCtD
Esomeprazole—Shock—Epirubicin—uterine cancer	0.000195	0.000331	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—uterine cancer	0.000194	0.00033	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000194	0.00033	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—uterine cancer	0.000194	0.00033	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—uterine cancer	0.000193	0.000329	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—uterine cancer	0.000192	0.000327	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—uterine cancer	0.000191	0.000326	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—uterine cancer	0.000191	0.000325	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—uterine cancer	0.000191	0.000325	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—uterine cancer	0.000191	0.000325	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—uterine cancer	0.00019	0.000324	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00019	0.000323	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—uterine cancer	0.000189	0.000321	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—uterine cancer	0.000189	0.000321	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—uterine cancer	0.000187	0.000318	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—uterine cancer	0.000185	0.000314	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—uterine cancer	0.000183	0.000312	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—uterine cancer	0.000182	0.00031	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00018	0.000307	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—uterine cancer	0.00018	0.000307	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—uterine cancer	0.00018	0.000306	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000179	0.000305	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—uterine cancer	0.000179	0.000305	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—uterine cancer	0.000179	0.000304	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—uterine cancer	0.000178	0.000303	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—uterine cancer	0.000178	0.000303	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—uterine cancer	0.000177	0.000301	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—uterine cancer	0.000177	0.0003	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—uterine cancer	0.000176	0.0003	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—uterine cancer	0.000175	0.000297	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—uterine cancer	0.000174	0.000297	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—uterine cancer	0.000172	0.000293	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000171	0.000291	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—uterine cancer	0.000171	0.00029	CcSEcCtD
Esomeprazole—Pain—Epirubicin—uterine cancer	0.000169	0.000288	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—uterine cancer	0.000169	0.000288	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000167	0.000284	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—uterine cancer	0.000166	0.000282	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—uterine cancer	0.000165	0.00028	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—uterine cancer	0.000163	0.000278	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—uterine cancer	0.000163	0.000278	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—uterine cancer	0.000163	0.000277	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—uterine cancer	0.000162	0.000275	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—uterine cancer	0.000161	0.000274	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—uterine cancer	0.000159	0.000271	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000158	0.000269	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—uterine cancer	0.000158	0.000269	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—uterine cancer	0.000157	0.000268	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—uterine cancer	0.000157	0.000267	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—uterine cancer	0.000157	0.000267	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—uterine cancer	0.000157	0.000266	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—uterine cancer	0.000157	0.000266	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—uterine cancer	0.000151	0.000257	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00015	0.000255	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—uterine cancer	0.000146	0.000248	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—uterine cancer	0.000146	0.000248	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—uterine cancer	0.000145	0.000246	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—uterine cancer	0.000145	0.000246	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—uterine cancer	0.000142	0.000242	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—uterine cancer	0.00014	0.000238	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—uterine cancer	0.000136	0.000231	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—uterine cancer	0.000135	0.00023	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—uterine cancer	0.000131	0.000224	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—uterine cancer	0.000131	0.000223	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—uterine cancer	0.00013	0.000221	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—uterine cancer	0.000126	0.000214	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Esomeprazole—Rash—Epirubicin—uterine cancer	0.000125	0.000212	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—uterine cancer	0.000125	0.000212	CcSEcCtD
Esomeprazole—Headache—Epirubicin—uterine cancer	0.000124	0.000211	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—uterine cancer	0.000121	0.000206	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—uterine cancer	0.000118	0.0002	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—uterine cancer	0.000117	0.000198	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—uterine cancer	0.000116	0.000197	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—uterine cancer	0.000115	0.000196	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—uterine cancer	0.000115	0.000195	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—uterine cancer	0.000109	0.000185	CcSEcCtD
